Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.912
+0.040 (4.59%)
Apr 18, 2024, 3:07 PM EDT - Market open
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for DNA stock have an average target of 2.20, with a low estimate of 1.10 and a high estimate of 3.00. The average target predicts an increase of 141.33% from the current stock price of 0.91.
Analyst Consensus: Hold
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for DNA stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 5 | 5 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $7 → $3 | Buy | Maintains | $7 → $3 | +229.09% | Mar 1, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $1.25 → $1.1 | Strong Sell | Maintains | $1.25 → $1.1 | +20.67% | Jan 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $1.25 → $1.1 | Strong Sell | Maintains | $1.25 → $1.1 | +20.67% | Jan 22, 2024 |
| Raymond James | Raymond James | Buy → Hold Downgrades $2.5 | Buy → Hold | Downgrades | $2.5 | +174.24% | Nov 15, 2023 |
| Raymond James | Raymond James | Buy → Hold Downgrades $2.5 | Buy → Hold | Downgrades | $2.5 | +174.24% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
225.78M
from 251.46M
Decreased by -10.21%
Revenue Next Year
313.31M
from 225.78M
Increased by 38.77%
EPS This Year
-0.32
from -0.46
EPS Next Year
-0.27
from -0.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 238.3M | 418.2M | 488.1M | 887.7M | 1.2B |
| Avg | 225.8M | 313.3M | 428.4M | 847.1M | 1.1B |
| Low | 213.1M | 278.5M | 350.3M | 815.4M | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.2% | 85.2% | 55.8% | 107.2% | 39.5% |
| Avg | -10.2% | 38.8% | 36.7% | 97.7% | 34.2% |
| Low | -15.3% | 23.4% | 11.8% | 90.3% | 30.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.29 | -0.22 | -0.18 | 0.02 | -0.11 |
| Avg | -0.32 | -0.27 | -0.20 | 0.02 | -0.10 |
| Low | -0.37 | -0.35 | -0.24 | 0.02 | -0.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.